GenePOC Gets Additional Debiopharm Investment; on Track to Launch Spinning Disk PCR Platform

Sep 01, 2016

|

Premium

NEW YORK (GenomeWeb) –GenePOC announced this week that Swiss pharmaceutical company Debiopharm has invested "tens of millions of dollars" into accelerating development of the Quebec City-based firm's molecular diagnostic platform and infectious disease assays.

The new funding will be used to support commercialization as well as to "continue our new assay development and have a constant flow of approximately two assays per year launched into the market," Herbert Torfs, GenePOC's vice president of business development and strategy, told GenomeWeb in an email.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

NIH Boost Proposed

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Police, Genealogy, and Privacy

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

Gotta Sequence 'Em All

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

This Week in Science

In Science this week: environmental DNA can help in studies of marine animals, and more.

Featured White Papers

Discovering Neuronal Cell Types

Highly Resolved Separation of DNA Fragments on the Fragment Analyzer

FEMTO Pulse Genomic DNA Sizing and Quality Control

xMAP Cookbook: A collection of methods and protocols for developing multiplex assays with xMAP Technology

Jun

19

Featured Webinar

RNA in situ Hybridization: The Next Generation of Immunohistochemistry?

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun

21

Featured Webinar

Evaluation & Implementation of NGS Liquid Biopsy Assays

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.

Jul

12

Featured Webinar

GW/ABRF 2018 Webinar Series: Analyzing the Human Brainome to Understand Alzheimer’s Disease Development : Genome, Transcriptome, Proteome, and Phenome Interaction in Human Cortex

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.

Aug

20

Featured Webinar

GenomeWeb/ABRF 2018 Webinar Series: Advances in Single-Cell RNA-Seq: Novel Technologies, Practical Applications

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.

Main menu